AX

Axiom Bio

7 known investors

axi.om ↗

Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.

Investors · 7

AB

Abstract VenturesSan Francisco · $100K – $1M

AM

Amplify PartnersMenlo Park · $500K – $5M

CR

CRV (Charles River Ventures)Bay Area · $250K – $5M

IN

Inception Studio CapitalSilicon Valley · $100K – $1.5M

AB

AbstractreportedSan Francisco · $250K – $750K

AT

Atria VenturesreportedSan Francisco · $500K – $3Mvia Chris Leiter · inferred

DI

Dimension CapitalreportedSan Francisco · $1M – $10M